PX1 Research supplies high-purity, laboratory-grade Livagen peptide for sale strictly designated for in vitro, cell culture, and analytical investigation. Every batch undergoes rigorous quality testing—including analytical HPLC purity verification, tandem mass spectrometry sequence validation, and quantitative endotoxin screening—to ensure reliable, reproducible experimental outcomes.
PX1 Research supplies high-purity, laboratory-grade Livagen peptide for sale strictly designated for in vitro, cell culture, and analytical investigation. Every batch undergoes rigorous quality testing—including analytical HPLC purity verification, tandem mass spectrometry sequence validation, and quantitative endotoxin screening—to ensure reliable, reproducible experimental outcomes.
When purchasing livagen peptide for sale, research institutions and qualified investigators require absolute analytical precision, batch-to-batch consistency, and fully transparent documentation. Livagen is a synthetic short peptide belonging to the bioregulatory peptide class, widely investigated in cell culture systems and preclinical models for its interactions with nuclear chromatin and gene expression pathways. Obtaining research-grade material free from synthesis byproducts, residual TFA, or bacterial lipopolysaccharides is essential for obtaining valid, non-artifactual experimental data.
PX1 Research provides analytical-grade research peptides manufactured within domestic, GMP-compliant facilities. Investigators sourcing compounds from our catalog of research peptides receive comprehensive verification documentation, including lot-specific certificates of analysis (COAs) generated by ISO 17025 accredited analytical laboratories. All inventory is maintained under strict environmental controls and dispatched directly from our dual logistics hubs in California and Arizona to preserve structural integrity.
Livagen is a synthetic peptide structurally classified as a short peptide bioregulator, composed of four amino acid residues (Lys-Glu-Asp-Ala or Lysine-Glutamic Acid-Aspartic Acid-Alanine). Operating as a low-molecular-weight oligopeptide, Livagen exhibits a distinct conformational flexibility that permits targeted interaction with genomic DNA and associated nuclear proteins within isolated cell models.
In analytical investigations, the primary sequence and chemical purity of Livagen are confirmed using high-performance liquid chromatography (HPLC) coupled with electrospray ionization mass spectrometry (ESI-MS). The low molecular mass facilitates rapid cellular uptake during in vitro assays, allowing researchers to evaluate nuclear translocation, promoter region binding, and transcriptomic shifts without requiring complex carrier vehicles or invasive permeabilization techniques. Understanding these physicochemical properties is foundational when structuring assays in epigenetic research.
Preclinical studies suggest that Livagen interacts directly with decondensed regions of nuclear chromatin, modulating the spatial architecture of histone proteins and DNA strands. In vitro models utilizing human lymphocytes and hepatocyte cell lines indicate that short bioregulatory peptides can bind specifically to the major and minor grooves of double-stranded DNA, inducing localized decondensation of heterochromatin into transcriptionally active euchromatin.
In vitro data indicate that this localized chromatin unwinding correlates with altered expression profiles of specific ribosomal genes and enzymes involved in protein synthesis. Rather than acting as a classical membrane-receptor agonist or antagonist, Livagen appears to function as a direct epigenetic modulator. Researchers investigating cell senescence pathways frequently monitor how Livagen influences histone acetylation status, DNA methyltransferase activity, and transcription factor accessibility across various cell passages.
Scientific literature surrounding Livagen primarily centers on its biological activity within hepatic tissue cultures and immunocompetent cell lines. Preclinical research models evaluating primary hepatocyte cultures demonstrate that exposure to Livagen influences the transcription of intracellular antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase, when cells are exposed to oxidative stress agents.
Additional research in elderly mammalian lymphocyte models suggests that Livagen can reactivate silent ribosomal genes that normally undergo progressive transcriptional silencing during cellular aging. By restoring transcription factor access to nucleolar organizer regions, Livagen provides a unique model system for studying chromatin activation, nucleolar structural integrity, and the reversal of age-associated heterochromatinization in non-human experimental paradigms.
Within the broader domain of peptide bioregulator research, Livagen is frequently evaluated alongside structurally distinct short peptides that target complementary cellular pathways. For instance, Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) extensively studied for its interaction with telomerase activity and pineal gland gene regulation, whereas Vilon is a Lys-Glu dipeptide focused predominantly on thymic cell proliferation and cytokine gene expression. Similarly, Bronchogen is studied for its specific affinity toward respiratory epithelial tissue models.
While Epitalon influences telomeric elongation markers and Vilon targets immune lineage activation, Livagen's primary focus in published literature remains localized to hepatic gene activation, nucleolar chromatin reactivation, and cellular protein synthesis machinery. Comparing these peptides within multi-arm in vitro panels enables investigators to map tissue-specific responses, binding kinetics, and differential gene expression profiles across diverse mammalian cell lines.
Assuring high purity in research compounds is vital for preventing experimental confounders. When evaluating any livagen peptide for sale, investigators must review analytical documentation that validates sequence accuracy and quantifies trace impurities. PX1 Research subjects every batch of synthetic peptides to rigorous independent testing protocols prior to release.
Purity is measured using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a baseline chemical purity of equal to or greater than 98%. Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) or ESI-MS verifies exact mass spectrometry matching the theoretical molecular weight of the sequence. Crucially, chromogenic Limulus Amebocyte Lysate (LAL) assays are performed to ensure endotoxin levels remain below strict laboratory thresholds (<0.01 EU/μg), mitigating inflammatory artifacts in sensitive cell culture experiments.
Lyophilized Livagen must be reconstituted under aseptic laboratory conditions using appropriate sterile solvents based on the intended analytical endpoint. For general cell culture and biochemical assays, sterile Bacteriostatic Water or Sterile Water for Injection (WFI) represents the standard solvent choice. For detailed preparation guidelines, researchers can refer to our peptide reconstitution guide.
To perform reconstitution, allow the sealed vial to equilibrate to room temperature before introducing the solvent along the internal glass wall. Gently swirl the solution until fully dissolved; avoid vigorous vortexing, which can induce physical shear stress and potential peptide denaturation. For cell culture experiments requiring specific osmolarity or pH conditions, aliquoting into sterile phosphate-buffered saline (PBS) or culture media immediately prior to application is recommended.
Lyophilized Livagen powder demonstrates high thermodynamic stability when stored at -20°C or -80°C in a desiccated environment protected from light exposure. Under these optimal conditions, the un-reconstituted peptide maintains chemical stability and sequence integrity for extended periods, preventing moisture-induced hydrolysis.
Once reconstituted into aqueous solution, liquid aliquots should be used immediately or stored at -80°C to minimize degradation over time. Repeated freeze-thaw cycles must be strictly avoided, as thermal fluctuations promote aggregation and enzymatic breakdown. Experimental facilities ordering bulk research supplies should plan aliquot volumes corresponding to single-assay requirements to guarantee uniform concentration and structural purity across long-term experimental series.
Navigating the research peptide marketplace requires selecting vendors that maintain full accountability across synthesis, purification, analytical verification, and cold-chain logistics. PX1 Research operates under a science-first model designed specifically to support university laboratories, biotechnology firms, and independent research institutions.
Our operational framework includes domestic USA manufacturing inside state-of-the-art facilities, batch-level lot traceability, third-party ISO 17025 analytical verification, and fast domestic fulfillment. Orders placed Monday through Friday ship same-day from our dual distribution centers in California and Arizona. By upholding strict quality control measures, PX1 Research eliminates supply chain variables, allowing researchers to focus entirely on generating accurate, reproducible data.
What is the primary application of Livagen in research settings?
Livagen is supplied exclusively as a research-grade reference compound for in vitro, cell culture, and biochemical investigation. Scientific literature focuses on its interactions with nuclear chromatin, gene expression modulation in hepatocytes and lymphocytes, and nucleolar structure during cellular aging studies.
How is the purity of PX1 Research Livagen verified?
Every lot of Livagen undergoes third-party analytical testing at an ISO 17025 accredited laboratory. Purity is confirmed to be ≥98% using Reverse-Phase HPLC, sequence mass is validated via mass spectrometry (ESI-MS/MALDI-TOF), and endotoxin content is quantified using LAL assay testing.
What sequence and molecular structure does Livagen possess?
Livagen is a synthetic short tetrapeptide consisting of the amino acid sequence Lysine-Glutamic Acid-Aspartic Acid-Alanine (Lys-Glu-Asp-Ala). It exhibits a low molecular mass that facilitates direct interaction with genomic material in in vitro models.
What solvent should be used to reconstitute Livagen for lab assays?
Sterile Bacteriostatic Water or Sterile Water for Injection (WFI) is commonly used to dissolve lyophilized Livagen. Once dissolved, aliquots can be further diluted into sterile PBS or specialized cell culture media depending on experimental requirements.
How should reconstituted Livagen solutions be stored?
Reconstituted liquid solutions should be divided into single-use experimental aliquots and frozen at -80°C to maintain stability. Multiple freeze-thaw cycles must be avoided to prevent physical denaturation or cleavage of the peptide chain.
Can Livagen be ordered in bulk for large-scale institutional research?
Yes, PX1 Research provides scalable sourcing options for university, enterprise, and institutional laboratories through our wholesale portal, supporting high-throughput screening and long-term multi-plate study designs.
What is the difference between Livagen and Epitalon?
While both are synthetic short peptides within the bioregulator class, Livagen (Lys-Glu-Asp-Ala) is studied primarily for hepatic gene expression and nucleolar chromatin reactivation, whereas Epitalon (Ala-Glu-Asp-Gly) is investigated for telomerase activity and pineal gland signaling.
Is Livagen approved for human therapeutic or medical use?
No. Livagen is strictly a research chemical designated for laboratory, in vitro, and preclinical research applications only. It is not approved for human or veterinary use, medical diagnosis, treatment, or clinical administration.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.